Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Non Operating Income (2018 - 2025)

Neurogene (NGNE) has disclosed Non Operating Income for 5 consecutive years, with $2.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non Operating Income changed N/A year-over-year to $2.8 million, compared with a TTM value of $12.2 million through Sep 2025, changed N/A, and an annual FY2024 reading of $7.5 million, down 61.27% over the prior year.
  • Non Operating Income was $2.8 million for Q3 2025 at Neurogene, down from $4.1 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $4.1 million in Q2 2025 and bottomed at $1.6 million in Q2 2024.